Grants and Contributions:
Title:
ARP - Feasibility - Artificial Eye Development for Ocular Biomarker Assessment
Agreement Number:
1003718
Agreement Value:
$75,000.00
Agreement Date:
Apr 1, 2023 - Mar 31, 2024
Description:
The association of ocular biomarkers with systemic health and disease ("Oculomics") is rapidly developing. It offers a unique opportunity to deepen the understanding of eye-body relationships and to support the development of new diagnostic tools by non-invasive means. The creation of in vitro and digital artificial eye models would accelerate the development of blood biomarker applications. Such platforms provide an innovative avenue for future breakthroughs related to the development of new biomarkers associated with ocular and general health conditions.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G1K 3G5
Reference Number:
172-2022-2023-Q4-1003718
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
819510900
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 60 days.
Amendment Date
Dec 21, 2023
Recipient's Legal Name:
Zilia inc.
Federal Riding Name:
Québec
Federal Riding Number:
24059
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: